SIGNATURE Study: Post-market, Randomized Controlled, Multicenter, Single Blinded Prospective Trial Investigating the Paclitaxel-Coated Balloon (Legflow DCB) Treatment Versus Uncoated Balloon Angioplasty Treatment for Femoro-popliteal Lesions
Latest Information Update: 15 Feb 2023
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral artery restenosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms SIGNATURE
- 07 Feb 2023 Planned End Date changed from 1 Sep 2024 to 1 May 2026.
- 07 Feb 2023 Planned primary completion date changed from 1 Sep 2023 to 1 May 2025.
- 10 Aug 2022 Planned number of patients changed from 140 to 148.